Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | RVTY | HQY | ||
| Company | Charles River Laboratories | Revvity Inc | Healthequity | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 235.00 | 113.48 | 95.00 | ||
| High | 237.86 | 114.16 | 95.15 | ||
| Low | 232.61 | 111.84 | 93.23 | ||
| Latest | 233.41 | 112.29 | 94.40 | ||
| Change | -0.19 | -0.66 | -0.41 | ||
| % Change | -0.08% | -0.58% | -0.43% | ||
| Volume | 873,200 | 929,100 | 623,600 | ||
| 20-Day Average Volume | 879,580 | 1,521,150 | 1,008,105 | ||
| Previous Close | 233.60 | 112.95 | 94.81 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 208.91 | 107.03 | 89.56 | ||
| 20-Day Raw Stochastic | 92.45% | 79.95% | 74.15% | ||
| 20-Day Relative Strength | 70.61 | 60.79 | 60.46 | ||
| Weighted Alpha | +55.94 | +19.21 | +4.60 | ||
| Today's Opinion | 88% Buy | 88% Buy | 72% Buy | ||
| Previous Opinion | 72% Buy | 88% Buy | 72% Buy | ||
| Last Month's Opinion | 8% Sell | 56% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.18% since 07/02/26 | -1.29% since 07/02/26 | -0.95% since 07/02/26 | ||
| Low | 218.38 on 07/08/26 | 108.02 on 07/08/26 | 91.94 on 07/09/26 | ||
| High | 237.86 on 07/10/26 | 114.16 on 07/10/26 | 98.34 on 07/07/26 | ||
| 1-Month | |||||
| %Chg | +25.29% since 06/10/26 | +10.86% since 06/10/26 | +5.22% since 06/10/26 | ||
| Low | 178.92 on 06/22/26 | 96.86 on 06/17/26 | 83.10 on 06/25/26 | ||
| High | 237.86 on 07/10/26 | 116.16 on 06/26/26 | 98.34 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +32.88% since 04/10/26 | +25.06% since 04/10/26 | +21.09% since 04/10/26 | ||
| Low | 146.20 on 05/19/26 | 81.22 on 04/29/26 | 76.03 on 04/13/26 | ||
| High | 237.86 on 07/10/26 | 116.16 on 06/26/26 | 98.34 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +5.66% since 01/09/26 | +7.53% since 01/09/26 | +0.27% since 01/09/26 | ||
| Low | 146.20 on 05/19/26 | 81.22 on 04/29/26 | 72.76 on 02/17/26 | ||
| High | 237.86 on 07/10/26 | 118.30 on 01/22/26 | 98.34 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,242,891 | 12,527,071 | 7,892,028 | ||
| Shares Outstanding, K | 48,168 | 111,560 | 83,602 | ||
| Annual Sales | 4,015,380,000 | 2,856,050,000 | 1,313,430,000 | ||
| Annual Net Income | -144,340,000 | 241,200,000 | 215,200,000 | ||
| Last Quarter Sales | 995,830,000 | 711,120,000 | 354,640,000 | ||
| Last Quarter Net Income | -14,840,000 | 40,720,000 | 69,420,000 | ||
| 60-Month Beta | 1.40 | 1.09 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.06 on 05/07/26 | 1.06 on 05/05/26 | 1.24 on 05/28/26 | ||
| Earnings Date | 08/05/26 | 08/04/26 | 09/01/26 | ||
| Most Recent Dividend | N/A | 0.070 on 04/17/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/17/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.36 | 22.06 | 26.41 | ||